期刊文献+

2011年美国肥厚型心肌病诊治指南解析 被引量:5

Interpretation of guidelines on 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
原文传递
导出
摘要 2011年11月8日,ACCF/AHA两大学会联合发表了肥厚型心肌病(HCM)诊断和治疗指南,这是国际几大学会首次针对这一疾病撰写指南,凸显了对肥厚型心肌病的重视,也体现了HCM近年来研究和发展及其迅速。指南分别从流行病学、临床定义、鉴别诊断、病程进展、病理生理学、诊断、疾病管理、其他问题和未来研究需要等各方面做了系统论述。 The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) jointly published the guideline for the diagnosis and treatment of hypertrophic cardiomyopathy in November 8,2011. This was the first time that the several international associations wrote guideline for the disease, which reflected the importance of HCM and development of research about HCM. The guideline did a systematic review from prevalence, clinical definition, differential diagnosis, clinical course, pathophysiology, diagnosis, management, other issues and future research, respectively. Our article had the brief interpretation of the guideline.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2012年第7期525-528,共4页 Chinese Journal of Practical Internal Medicine
关键词 肥厚型心肌病 诊治指南 美国心脏病学会基金会 美国心脏学会 hypertrophic cardiomyopathy guidelines ACCF AHA
作者简介 yunlong.xia@gmail.com
  • 相关文献

参考文献12

  • 1Bernard JG, Barry JM, Joseph AD, et a12011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy [ J]. JACC,2011,58:735 - 1097.
  • 2Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and thera- peutic implications of genetic testing for hypertrophic cardiomyopa- thy [ J]. J Am Coil Cardiol,2009 ,54 :201 - 211.
  • 3Maron BJ, Spirito P. Implantable de? brillators and prevention of suddendeath in hypertrophic cardiomyopathy [ J ]. Cardiovasc Elec- trnphysiol,2008 ,19 :1118 - 1126.
  • 4Sorajja P, Valeti U, Nishimura RA, et al Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy [ J ]. Circula-tion,2008,118 : 131 - 139.
  • 5Bunch TJ, Munger TM, Friedman PA, et al Substrate and procedural predictors of outcomes after catheter ablation for atrial ? brillation in patients with hypertrophic cardiomyopathy [ J ]. Cardiovasc Electm- physiol,2008,19 : 1009 - 1014.
  • 6Morita H, Rehm HL, Menesses A, et al Shared genetic causes of car- diac hypertrophy in children and adults [ J ]. N Engl J Med, 2008, 358:1899 - 1908.
  • 7Christiaans I, Lekanne dit Deprez RH, van Langen IM, et al Ventric- ular? bfillation in MYH7-related hypertrophic cardiomyopathy be- fore onset of ventricular hypertrophy [J].Heart Rhythm, 2009,6 : 1366 - 1369.
  • 8Andersen PS, Havndrup O, Hougs L, et al Diagnostic yield, interpre- tation, and clinical utility of mutation screening of sarcomere enco- ding genes in Danish hypertrophic cardiomyopathy patients and rela- tives [ J]. Hum Mutat,2009,30:363 - 370.
  • 9Christiaans I, Bimie E, van Langen IM, et al The yield of risk strati .9 cation for sudden cardiac death in hypertrophic cardiomyopathy my- osinbinding protein C gene mutation carriers: focus on predictive screening[ J]. Eur Heart J ,2010,31:842 -848.
  • 10Michels M, Soliman OI, Phefferkorn J, et al Disease penetrance and risk strati? cation for sudden cardiac death in asymptomatic hyper- trophic cardiomyopathy mutation carriers [ J ]. Eur Heart J, 2009, 30:2593 - 2598.

同被引文献33

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部